Name of author | Region | Study design | Sample size | Response rate | Cutoffs used (μg/dl) | Prevalence | Quality score |
---|---|---|---|---|---|---|---|
Gebremedhin S et al 2011 | SNNP | Cross-sectional | 750 | 93.3% | Serum zinc < 56 in the 1st TM and < 50 during the 2nd or 3rd TM | 53% | 9 |
Stoecke BJ et al 2009 | SNNP | Cross-sectional | 99 | 100% | Plasma Zinc< 50 | 76% | 7 |
Afework K et al 2008 | Amhara | Cross-sectional | 375 | 100% | Serum zinc level <75 | 66.7% | 7 |
Regassa K 2017 | Addis Ababa | Cross-sectional | 403 | 100 | Serum zinc level <75 | 39.5% | 7 |
Kumera G K et al 2015 | Amhara | Cross-sectional | 377 | 96.5 % | Serum zinc level < 56 in the 1st TM and <50 during 2nd and 3rd TM | 57.4 % | 8 |
Rosalind S et al 2008 | SNNP | Cross-sectional | 99 | 100% | Plasma zinc <50 | 74% | 7 |
Mekonen A 2016 | Gambela | Cross-sectional | 268 | 100% | Serum zinc < 56 during the 1st TM and < 50 during the 2nd or 3rd TM | 55.3% | 8 |